Lexicon Pharmaceuticals Inc (NAS:LXRX)
$ 0.7734 -0.01075 (-1.37%) Market Cap: 279.58 Mil Enterprise Value: 122.41 Mil PE Ratio: 0 PB Ratio: 1.57 GF Score: 44/100

Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 03:30PM GMT
Release Date Price: $4.24 (-0.47%)
Jessica Macomber Fye
JP Morgan Chase & Co, Research Division - Analyst

Great. Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan, and we're continuing the 2020 healthcare conference today with Lexicon.

We're going to host a Q&A session with the management team immediately after this presentation. It's going to be just down the hall in the Yorkshire Room, so come to that after if you want to hear more. But for the presentation, I'm going to turn it over to the company's CEO, Lonnel Coats.

Lonnel Coats
Lexicon Pharmaceuticals, Inc. - President, CEO & Director

Thank you, Jessica. And as always, I will make this presentation on behalf of all the extraordinary men and women at Lexicon who work tirelessly to bring our innovations forward to patients.

Today, I'll be making forward-looking statements. In some of those statements, there will be risks. Our risks are identified in our SEC filings.

So let me jump right in. Lexicon's scientific platform has produced 2 approved products and a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot